|

Hematopoietic stem cell transplant (HSCT) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Paul Szabolcs1

Indications

  • Omenn Syndrome1
  • Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome1
  • Hypomorphic RAG2 Deficiency1
  • CD40 Deficiency1
  • GATA2 Associated Immunodeficiency1

Pittsburgh, Pennsylvania1 trial

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

UPMC Children's Hospital of Pittsburgh

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.